These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38641496)

  • 21. The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.
    Tsai YH; Hsieh MJ; Chang CJ; Wen YW; Hu HC; Chao YN; Huang YC; Yang CT; Huang CC
    Vaccine; 2015 Jun; 33(25):2897-902. PubMed ID: 25936662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of functional antibacterial opsonophagocytic antibodies elicited by 13-valent pneumococcal conjugate vaccine administered concomitantly with trivalent influenza vaccine in a randomized clinical trial in adults aged ≥65 years.
    Schwarz TF; Schmoele-Thoma B
    Vaccine; 2013 Jan; 31(2):291-4. PubMed ID: 23123107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults.
    Frenck RW; Gurtman A; Rubino J; Smith W; van Cleeff M; Jayawardene D; Giardina PC; Emini EA; Gruber WC; Scott DA; Schmöle-Thoma B
    Clin Vaccine Immunol; 2012 Aug; 19(8):1296-303. PubMed ID: 22739693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccine.
    Stockwell MS; Broder K; LaRussa P; Lewis P; Fernandez N; Sharma D; Barrett A; Sosa J; Vellozzi C
    JAMA Pediatr; 2014 Mar; 168(3):211-9. PubMed ID: 24395025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual influenza and pneumococcal vaccination was associated with lower short-term risks of all-cause and acute respiratory hospitalizations among the elderly in Shenzhen, China: a retrospective cohort study.
    Jiang Y; Ye Z; Chen D; Shu Y
    Emerg Microbes Infect; 2020 Dec; 9(1):2578-2587. PubMed ID: 33215981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab.
    Berglund A; Willén L; Grödeberg L; Skattum L; Hagberg H; Pauksens K
    Acta Oncol; 2014 Sep; 53(9):1212-20. PubMed ID: 24865118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.
    Tse A; Tseng HF; Greene SK; Vellozzi C; Lee GM;
    Vaccine; 2012 Mar; 30(11):2024-31. PubMed ID: 22361304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A narrative review on vaccination rate and factors associated with the willingness to receive pneumococcal vaccine in Chinese adult population.
    Yunhua B; Peng B; Shuping L; Zheng Z
    Hum Vaccin Immunother; 2022 Nov; 18(6):2139123. PubMed ID: 36379017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-Effectiveness Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine Program for the Elderly Aged 60 Years or Older in Shanghai, China.
    Sun X; Tang Y; Ma X; Guo X; Huang Z; Ren J; Qiu J; Jiang H; Lu Y
    Front Public Health; 2021; 9():647725. PubMed ID: 34109145
    [No Abstract]   [Full Text] [Related]  

  • 30. Febrile Seizures After 2010-2011 Trivalent Inactivated Influenza Vaccine.
    Kawai AT; Martin D; Kulldorff M; Li L; Cole DV; McMahill-Walraven CN; Selvam N; Selvan MS; Lee GM
    Pediatrics; 2015 Oct; 136(4):e848-55. PubMed ID: 26371192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency.
    Loubet P; Kernéis S; Groh M; Loulergue P; Blanche P; Verger P; Launay O
    Vaccine; 2015 Jul; 33(31):3703-8. PubMed ID: 26073016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers.
    Gilchrist SA; Nanni A; Levine O
    Am J Public Health; 2012 Apr; 102(4):596-605. PubMed ID: 22397339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity and safety of zoster vaccine live administered with quadrivalent influenza virus vaccine.
    Levin MJ; Buchwald UK; Gardner J; Martin J; Stek JE; Brown E; Popmihajlov Z
    Vaccine; 2018 Jan; 36(1):179-185. PubMed ID: 28830693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years.
    Schwarz TF; Flamaing J; Rümke HC; Penzes J; Juergens C; Wenz A; Jayawardene D; Giardina P; Emini EA; Gruber WC; Schmoele-Thoma B
    Vaccine; 2011 Jul; 29(32):5195-202. PubMed ID: 21619909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.
    Domínguez A; Castilla J; Godoy P; Delgado-Rodríguez M; Saez M; Soldevila N; Astray J; Mayoral JM; Martín V; Quintana JM; González-Candelas F; Galán JC; Tamames S; Castro A; Baricot M; Garín O; Pumarola T;
    Hum Vaccin Immunother; 2013 Apr; 9(4):865-73. PubMed ID: 23563516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Annual report: Surveillance of adverse events following immunisation in Australia, 2011.
    Mahajan D; Cook J; Dey A; Macartney K; Menzies RI
    Commun Dis Intell Q Rep; 2012 Dec; 36(4):E315-32. PubMed ID: 23330706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older.
    Dos Santos G; Devadiga R; Kim CS; Bang J
    Drug Saf; 2024 Apr; 47(4):365-375. PubMed ID: 38483767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of mortality and pneumonia among nursing home older adults by dual pneumococcal and seasonal influenza vaccination during a pandemic caused by novel pandemic influenza A (H1N1).
    Chan TC; Hung IF; Luk JK; Shea YF; Chan FH; Woo PC; Chu LW
    J Am Med Dir Assoc; 2012 Oct; 13(8):698-703. PubMed ID: 22722051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine responses in patients with rheumatoid arthritis treated with certolizumab pegol: results from a single-blind randomized phase IV trial.
    Kivitz AJ; Schechtman J; Texter M; Fichtner A; de Longueville M; Chartash EK
    J Rheumatol; 2014 Apr; 41(4):648-57. PubMed ID: 24584918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza and pneumococcal vaccination in older veterans: results from the behavioral risk factor surveillance system.
    Chi RC; Reiber GE; Neuzil KM
    J Am Geriatr Soc; 2006 Feb; 54(2):217-23. PubMed ID: 16460371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.